Evolutionary speculation about tuberculosis and the metabolic and inflammatory processes of obesity

JAMA

Volumn 301, Issue 24, 2009, Pages 2586-2588

  Roth, Jesse ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; CALORIC INTAKE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFECTION CONTROL; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; LIFE EXPECTANCY; LIFESPAN; MALNUTRITION; METABOLIC SYNDROME X; MORTALITY; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; RISK REDUCTION; STARVATION; SURVIVAL; TUBERCULOSIS; ARTICLE; EVOLUTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY;

DISEASE SUSCEPTIBILITY; EVOLUTION; HUMANS; IMMUNITY, INNATE; METABOLIC SYNDROME X; OBESITY; TUBERCULOSIS;

EID: 67649231182     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.930     Document Type: Note

References (15)

1. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
2. Roth J, Qiang X, Marbán SL, Redel H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res. 2004;12(suppl 2):88S-101S.
3. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med. 2007;262(4):408-414.
4. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007;117(9):2621-2637.
5. Coleman DL. Obesity genes: beneficial effects in heterozygous mice. Science. 1979;203(4381):663-665.
6. Chung WK, Belfi K, Chua M, et al. Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am J Physiol. 1998;274(4 pt 2):R985-R990.
7. Ryan F. The Forgotten Plague: How the Battle Against Tuberculosis Was Won - and Lost. Boston, MA: Back Bay Books; 1994.
8. Young DB, Perkins MD, Duncan K, Barry CE III. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest. 2008;118(4):1255-1265.
9. Osler W. The Principles and Practice of Medicine. New York, NY: D Appleton & Co; 1892.
10. Leung CC, Lam TH, Chan WM, et al. Lower risk of tuberculosis in obesity. Arch Intern Med. 2007;167(12):1297-1304.
11. Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, et al; BIOBADASER Group. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum. 2005;52(6):1766-1772.
12. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169-1196.
13. Sommer A. Vitamin A deficiency and clinical disease: an historical overview. J Nutr. 2008;138(10):1835-1839.
14. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113-119.
15. Baldwin ER. Tuberculosis: history and etiology. In: Osler W, McCrae T, eds. Modern Medicine, Its Theory and Practice, in Original Contributions by American and Foreign Authors. Vol 3. Philadelphia, PA: Lea Brothers; 1907:137-199.